OTCPK:EHVV.F

Stock Analysis Report

Executive Summary

EHAVE, Inc., a healthcare company, engages in developing a medical cannabis and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Risks

  • EHAVE has significant price volatility in the past 3 months.
  • EHAVE is not covered by any analysts.

Share Price & News

How has EHAVE's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:EHVV.F

1.1%

US Healthcare Services

1.3%

US Market


1 Year Return

-99.1%

OTCPK:EHVV.F

6.6%

US Healthcare Services

2.0%

US Market

EHVV.F underperformed the Healthcare Services industry which returned 4.8% over the past year.

EHVV.F underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

EHVV.FIndustryMarket
7 Day0%1.1%1.3%
30 Day-0.3%-5.5%3.9%
90 Day-13.3%-4.9%3.4%
1 Year-99.1%-99.1%6.7%6.6%4.2%2.0%
3 Yearn/a49.4%49.1%47.2%37.6%
5 Yearn/a47.0%46.1%60.5%42.9%

Price Volatility Vs. Market

How volatile is EHAVE's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is EHAVE undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether EHAVE is trading at an attractive price based on the cash flow it is expected to produce in the future. But as EHAVE has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of EHVV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through EHAVE regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is EHAVE expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

28.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EHAVE has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of EHVV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access EHAVE's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has EHAVE performed over the past 5 years?

-72.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

EHAVE does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare EHAVE's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare EHAVE's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if EHAVE has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if EHAVE has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if EHAVE improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is EHAVE's financial position?


Financial Position Analysis

EHAVE's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

EHAVE's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

EHAVE has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if EHAVE's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

EHAVE has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

EHAVE has less than a year of cash runway based on current free cash flow.

Unable to confirm if EHAVE has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is EHAVE's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate EHAVE's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate EHAVE's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as EHAVE has not reported any payouts.

Unable to verify if EHAVE's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as EHAVE has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of EHAVE's salary, the management and board of directors tenure and is there insider trading?

1.4yrs

Average management tenure


CEO

Benjamin Kaplan 0

0.3yrs

Tenure

0

Mr. Benjamin Kaplan has been Chief Executive Officer of EHAVE, Inc since June 24, 2019. Mr. Kaplan is an entrepreneur and an investor in companies both public and private, with a focus on international gro ...


Management Age and Tenure

1.4yrs

Average Tenure

The average tenure for the EHAVE management team is less than 2 years, this suggests a new team.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Dave Goyette (57yo)

    Chief Technology Officer

    • Tenure: 2.5yrs
    • Compensation: US$291.30k
  • Dianne Parsons (55yo)

    Acting CFO & Controller

    • Tenure: 1.4yrs
  • Benjamin Kaplan

    Chief Executive Officer

    • Tenure: 0.3yrs

Board Members

  • Shimmy Posen (27yo)

    Chairman of the Board

    • Tenure: 0yrs
  • Zeke Kaplan (34yo)

    Director

    • Tenure: 1.1yrs

Company Information

EHAVE, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: EHAVE, Inc.
  • Ticker: EHVV.F
  • Exchange: OTCPK
  • Founded: 2011
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$764.957k
  • Shares outstanding: 25.41m
  • Website: https://www.ehave.com

Number of Employees


Location

  • EHAVE, Inc.
  • 277 Lakeshore Road East
  • Suite 203
  • Oakville
  • Ontario
  • L6J 6J3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EHVV.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 2016

Biography

EHAVE, Inc., a healthcare company, engages in developing a medical cannabis and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applicati ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:22
End of Day Share Price2019/09/12 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.